Your new experience awaits. Try the new design now and help us make it even better

PERSPECTIVE article

Front. Microbiol.

Sec. Systems Microbiology

This article is part of the Research TopicGenerative AI and Large Language Models in Microbial Evolution, Resistance Mechanisms, and Antimicrobial Drug DiscoveryView all articles

Generative AI in Microbial Evolution and Resistance: Toward Robust, Explainable, and Equitable Predictions

Provisionally accepted
  • Monash University, Melbourne, Australia

The final, formatted version of the article will be published soon.

Antimicrobial resistance (AMR) is one of the most urgent challenges in modern microbiology, both an evolutionary inevitability and a global health crisis shaped by clinical practices, ecological disruption, and social inequities. Generative artificial intelligence (AI) and large language models (LLMs) present new opportunities to anticipate resistance pathways, design novel antimicrobial agents, and guide interventions that are informed by evolutionary dynamics. Their successful integration, however, depends on addressing three fundamental imperatives. The first is evolutionary robustness, requiring models that incorporate mutation, horizontal gene transfer, and adaptive landscapes to move beyond retrospective classification toward predictive evolutionary inference. The second is explainability and biosafety, which demand interpretable and biologically credible outputs that clinicians, microbiologists, and policymakers can trust, while safeguarding against dual use risks. The third is data equity, which calls for strategies that mitigate structural biases in global microbial datasets and ensure that predictive systems serve the populations most affected by AMR. This Perspective advances the view that generative AI must be conceived as a transformative epistemic infrastructure that is evolution aware, transparent, and globally inclusive, capable of supporting sustainable drug discovery, adaptive surveillance, and equitable microbiological futures.

Keywords: Generative artificial intelligence, microbial evolution, antimicrobial resistance, Drug Discovery, Explainability and Biosafety

Received: 14 Sep 2025; Accepted: 17 Nov 2025.

Copyright: © 2025 Sufi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Fahim Sufi, research@fahimsufi.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.